Cellebrite DI Ltd(CLBT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 48.84 | EPS (ttm) | 0.23 | Insider Own | 50.58% | Shs Outstand | 249.4M | Perf Week | -2.54% |
| Market Cap | 2.82B | Forward P/E | 30.2 | EPS next Y | 35.88% | Insider Trans | -0.28% | Shs Float | 123.3M | Perf Month | -29.35% |
| Enterprise Value | 2.41B | PEG | 1.43 | EPS next Q | 0.09 | Inst Own | 44.62% | Short Float | 6.23% | Perf Quarter | -12.82% |
| Income | 0.06B | P/S | 5.49 | EPS this Y | -10.99% | Inst Trans | -1.41% | Short Ratio | 2.75 | Perf Half Y | -21.84% |
| Sales | 0.51B | P/B | 5.25 | EPS next 5Y | 21.13% | ROA | 6.54% | Short Interest | 7.68M | Perf YTD | -37.19% |
| Book/sh | 2.16 | P/C | 6.38 | EPS past 3/5Y | -19.38% 46.15% | ROE | 12.31% | 52W High | -43.32% ($19.98) | Perf Year | -33.77% |
| Cash/sh | 1.77 | P/FCF | 19.59 | Sales past 3/5Y | 20.68% 19.53% | ROIC | 10.48% | 52W Low | 18.22% ($9.58) | Perf 3Y | 43.72% |
| Dividend Est. | - | EV/EBITDA | 29.71 | EPS Y/Y TTM | 131.46% | Gross Margin | 82.96% | Volatility(W/M) | 3.7% 5% | Perf 5Y | 12.46% |
| Dividend TTM | - | EV/Sales | 4.68 | Sales Y/Y TTM | 17.76% | Oper. Margin | 11.36% | ATR (14) | 0.61 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.58 | EPS Q/Q | -67.77% | Profit Margin | 11.33% | RSI (14) | 38.47 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.6 | Sales Q/Q | 15.77% | SMA20 | -0.97% ($11.43) | Beta | 1.13 | Target Price | $15.36 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/8/13 | SMA50 | -18.24% ($13.85) | Rel Volume | 0.81 | Prev Close | $11.43 |
| Employees | 1285 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | -66.33% -0.28% | SMA200 | -22.43% ($14.59) | Avg Volume(3M) | 2.80M | Price | $11.32 |
| IPO | 2020/11/6 | Option/Short | Yes/Yes | Trades | 13609 | Volume | 2,262,376 | Change | -0.92% |
Company
CLBT is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔍 This is an Israeli company that provides digital intelligence software. It offers mobile forensic and investigation software that supports law enforcement agencies and enterprises in collecting and analyzing digital evidence, giving it exposure to the digital investigation needs of government and public-sector customers. It is a company in the digital intelligence sector.
Over the past 1 year, on the lower side
43% below its 1-year high.
CLBT makes money exceptionally well
11.36% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -11.0% this year.
Tap to view numbers
But it is not cheap
Trading at 48.8 times earnings.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +43.7% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 44.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DAT 0.03%
TMFG 0.02%
IZRL 0.02%
WCLD 0.01%
SGRW 0.01%It ranks #4 in the industry
Based on market cap of $3B.
CLBT $3B PER 48.8
MSFT $3.7T PER 27.4
ORCL $441B PER 26.3
PLTR $399B PER 141.8
FAQ
What kind of company is CLBT?
CLBT belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of CLBT?
The market cap of CLBT is approximately $2.8B, ranking 1,825 within its sector.
What is the P/E ratio of CLBT?
CLBT has a P/E ratio of approximately 48.8x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for CLBT?
CLBT has recorded a 52-week high of $19.98 and a low of $9.58.
